BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang R, Zhu Y, Xu J, Chen L, Su G, Kijlstra A, Yang P. Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease. Front Cell Dev Biol 2021;9:637489. [PMID: 33718374 DOI: 10.3389/fcell.2021.637489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu H, Hu L, Tang W, Chen G, Liu J, Li S, Xu Z. Clinical Comparative Study of Different Fundus Imaging Methods in the Acute Phase of Vogt-Koyanagi-Harada Disease. Evid Based Complement Alternat Med 2022;2022:5812090. [PMID: 36262163 DOI: 10.1155/2022/5812090] [Reference Citation Analysis]
2 Yang J, Li Y, Gao W, Feng Y, He X, Ni H, Song X, Fan J. Proteomic analysis reveals the heterogeneity of metabolic reprogramming in lacrimal gland tumors. Experimental Eye Research 2022;219:109052. [DOI: 10.1016/j.exer.2022.109052] [Reference Citation Analysis]
3 Joye A, Suhler E. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2021;32:574-82. [PMID: 34545845 DOI: 10.1097/ICU.0000000000000809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Ding S, Chen M, Liao Y, Chen Q, Lin X, Chen S, Chai Y, Li C, Asakawa T. Serum Metabolic Profiles of Chinese Women With Perimenopausal Obesity Explored by the Untargeted Metabolomics Approach. Front Endocrinol (Lausanne) 2021;12:637317. [PMID: 34630316 DOI: 10.3389/fendo.2021.637317] [Reference Citation Analysis]